昭衍新药

- 603127

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
昭衍新药(603127) 利润表
单位:万元
报表日期2022-03-312021-12-312021-09-302021-06-302021-03-31
一、营业总收入27,097.55151,668.0085,680.4453,455.6520,099.25
营业收入27,097.55151,668.0085,680.4453,455.6520,099.25
二、营业总成本17,851.49108,697.8568,999.3947,750.8711,132.49
营业成本13,091.5577,755.8043,091.1126,324.889,732.83
营业税金及附加226.56869.19639.89466.45160.54
销售费用394.671,597.251,161.09725.36319.77
管理费用6,392.2825,615.6219,553.6913,126.156,710.96
财务费用-3,482.49-1,915.581,051.624,921.98-6,779.50
研发费用1,228.914,775.563,501.992,186.05987.88
资产减值损失----------
公允价值变动收益3,835.2415,777.758,006.969,202.9890.25
投资收益425.081,700.001,199.52546.35178.71
其中:对联营企业和合营企业的投资收益---42.55------
汇兑收益----------
三、营业利润13,982.5564,288.9228,154.4717,386.6410,780.35
加:营业外收入0.0041.733.833.470.67
减:营业外支出6.86130.28128.09126.97377.42
其中:非流动资产处置损失----------
四、利润总额13,975.6964,200.3728,030.2117,263.1410,403.60
减:所得税费用1,487.748,558.743,329.261,953.811,093.59
五、净利润12,487.9555,641.6324,700.9515,309.349,310.00
归属于母公司所有者的净利润12,534.7455,745.9624,800.6215,373.499,335.73
少数股东损益-46.78-104.33-99.66-64.16-25.72
六、每股收益
基本每股收益(元/股)0.33001.51000.95000.60000.3900
稀释每股收益(元/股)0.33001.50000.94000.59000.3800
七、其他综合收益-103.15-247.72-144.18-236.65-3,071.11
八、综合收益总额12,384.8055,393.9124,556.7715,072.686,238.89
归属于母公司所有者的综合收益总额12,431.5955,498.2424,656.4315,136.846,264.62
归属于少数股东的综合收益总额-46.78-104.33-99.66-64.16-25.72
下载全部历史数据到excel中 返回页顶